Literature DB >> 10686310

Mycophenolate mofetil monotherapy: an example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients.

C Keunecke1, U Rothenpieler, B Zanker, H Schneeberger, W D Illner, J Theodorakis, M Stangl, W Land.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10686310     DOI： 10.1016/s0041-1345(00)00808-3

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Randomized trial of immunosuppressive regimens in renal transplantation.

Authors:  Giselle Guerra; Gaetano Ciancio; Jeffrey J Gaynor; Alberto Zarak; Randolph Brown; Lois Hanson; Junichiro Sageshima; David Roth; Linda Chen; Warren Kupin; Lissett Tueros; Phillip Ruiz; Alan S Livingstone; George W Burke
Journal:  J Am Soc Nephrol       Date:  2011-08-01       Impact factor: 10.121

Review 2.  Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation.

Authors:  Melissa Young; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Successful reduction of immunosuppression in older renal transplant recipients who exhibit donor-specific regulation.

Authors:  Ewa Jankowska-Gan; Hans W Sollinger; John D Pirsch; Junchao Cai; Julio Pascual; Lynn D Haynes; Alenjandro Munoz del Rio; William J Burlingham
Journal:  Transplantation       Date:  2009-08-27       Impact factor: 4.939

4.  Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients.

Authors:  Ahmed F Hamdy; Mohamed A Bakr; Mohamed A Ghoneim
Journal:  J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 10.121

Review 5.  Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result.

Authors:  Titte R Srinivas; Herwig-Ulf Meier-Kriesche
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

6.  Mycophenolic Acid for Topical Immunosuppression in Vascularized Composite Allotransplantation: Optimizing Formulation and Preliminary Evaluation of Bioavailability and Pharmacokinetics.

Authors:  Firuz G Feturi; Matthias Weinstock; Wenchen Zhao; Wei Zhang; Jonas T Schnider; Vasil E Erbas; Sinan Oksuz; Jan A Plock; Lisa Rohan; Alexander M Spiess; Lydia M Ferreira; Mario G Solari; Raman Venkataramanan; Vijay S Gorantla
Journal:  Front Surg       Date:  2018-05-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.